The vaccine is first offered to the healthcare workers, frontline workers and those above 50 years of age, followed by the below-50 population with comorbidities, and finally to the remaining population based on disease epidemiology and vaccine availability.
January 16, 2021
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said on Sunday.
December 6, 2020
Tehran, Nov 17: Iran’s Health Minister Saeed Namaki said on Monday that four Iranian companies have started human…
November 17, 2020
Requests for more than 1.2 billion doses of Sputnik V vaccine came from over 50 countries. The vaccine supplies for the global market will be produced by RDIF’s international partners in India, Brazil, China, South Korea and other countries
November 14, 2020
Health minister Zahid Maleque on Thursday said the International Centre for Diarrhoeal Disease Research, and Sinovac would jointly conduct the trial on uninfected healthcare employees
August 28, 2020
Amid the race to develop an effective vaccine against COVID-19 in record time, six candidates have now entered the late stage clinical trial, according to the New York Times vaccine tracker
July 29, 2020
According to a senior official, recently the ethics committee has given a go-ahead for human trials for the vaccine, and AIIMS will begin registering volunteers as per the procedure.
July 19, 2020
Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently
July 17, 2020
There are at least 21 vaccines currently under key trials, according to the World Health Organisation (WHO).
July 12, 2020
Hyderabad, June 29 : Leading vaccine maker Bharat Biotech on Monday announced that it has successfully developed Covaxin,…
June 29, 2020
A larger trial, of about 5,000 volunteers, will start in the coming months and will have no age limit.
April 24, 2020
The Indian Council of Medical Research (ICMR) also pitched for the Oxford vaccine on Sunday, saying ‘ChAdOX1' is the frontrunner in the race to take on the deadly COVID-19 virus.
April 22, 2020